Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Peter J. O'Dwyer, Kyriakos P. Papadopoulos, Anthony W. Tolcher, Ursina R. Teitelbaum, Kathleen Harlacker, Lon S. Smith, Davendra Sohal, Drew Warren Rasco, Muralidhar Beeram, Mariam Mehran, Manal Tawashi, Michel A. Drouin, James Wang, Marielle Fournel, Chr | ||||||||||||
Title | MGCD265, a multitargeted oral tyrosine kinase receptor inhibitor of Met and VEGFR, in combination with erlotinib in patients with advanced solid tumors. | ||||||||||||
|
|||||||||||||
URL | http://meetinglibrary.asco.org/content/96526-114 | ||||||||||||
Abstract Text | J Clin Oncol 30, 2012 (suppl; abstr e13602) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|